Therapeutic Antibodies – News and Features

Article
Purification Technologies Advancing Downstream Processing of Biopharmaceuticals
Explore cutting-edge technologies and workflows advancing downstream processing in biopharma, driving purification efficiency and innovation in new therapies.

Article
Accelerating Antibody Discovery With AI and Machine Learning
Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

News
“Molecular Shield” in the Nose Blocks Hay Fever Reactions
Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia. Delivered intranasally, it reduced allergic symptoms and inflammation in mice without systemic side effects.

News
Repurposed Drug May Reduce Cancer Immunotherapy Side Effect
A team of researchers has identified a potential new strategy to prevent, or even reverse, immune checkpoint inhibitor–induced type 1 diabetes.

Article
The Immune System in Cancer: Its Roles and How We Can Harness It
This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage a patient’s immune system to treat cancer.

News
Gum Disease Bacteria Detected in Joint Tissue, Could Trigger Rheumatoid Arthritis
A CU Anschutz study also identified the presence of a bacterium that causes gum disease in joint tissue, meaning it may play a role in the development of rheumatoid arthritis.

Article
The Evolution of Biomarkers in Modern Cancer Care
This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

News
FDA Approves Pembrolizumab for Advanced Head and Neck Cancer
Pembrolizumab, an immune checkpoint inhibitor, has been approved by the US Food and Drug Administration for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma whose tumors express PD-L1.

News
A New Tumor-Targeting System for Cancer-Fighting Cells
Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts on many types of cancer cells (Eva1) and successfully eliminated tumors in lab mice.

News
Electric Fields May Help the Immune System Fight Brain Cancer
A new Phase 2 trial suggests that using an electric field device placed on the scalp, along with immunotherapy and chemotherapy may help patients with glioblastoma live longer – particularly those with large, inoperable tumors.
Advertisement